"In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing."
Curious why we even wait seeing how it can't differentiate between the flu and Covid.
First Fauci, then WHO, and then FDA all admit there is malarkey in the PCR Tests, but have - until now, done nothing about it... allowing the daily fearmongering of soaring "cases" to enable their most twisted 1984-esque controls.
All of which brings us to today's announcement from The FDA, that it will be abandoning the PCR Test for COVID at the end of the year.
Audience: Individuals Performing COVID-19 Testing
Level: Laboratory Alert
After December 31, 2021, CDC will withdraw the request to the U.S. Food and Drug Administration (FDA) for Emergency Use Authorization (EUA) of the CDC 2019-Novel Coronavirus (2019-nCoV) Real-Time RT-PCR Diagnostic Panel, the assay first introduced in February 2020 for detection of SARS-CoV-2 only. CDC is providing this advance notice for clinical laboratories to have adequate time to select and implement one of the many FDA-authorized alternatives.
Visit the FDA website for a list of authorized COVID-19 diagnostic methods. For a summary of the performance of FDA-authorized molecular methods with an FDA reference panel, visit this page.
In preparation for this change, CDC recommends clinical laboratories and testing sites that have been using the CDC 2019-nCoV RT-PCR assay select and begin their transition to another FDA-authorized COVID-19 test. CDC encourages laboratories to consider adoption of a multiplexed method that can facilitate detection and differentiation of SARS-CoV-2 and influenza viruses. Such assays can facilitate continued testing for both influenza and SARS-CoV-2 and can save both time and resources as we head into influenza season. Laboratories and testing sites should validate and verify their selected assay within their facility before beginning clinical testing.
The question one is forced to ask is simple - as with everything else that happens in the Healthcare-Industrial-Complex - cui bono?
Is another provider of testing about to be enrichened?
Or is it even more sinister than standard crony capitalism? Given the traditional winter spike in 'flu' cases and the PCR-Test-driven "casedemic" we experienced into the election and through the start of the Biden administration, one could be forgiven for suggesting that the last thing an already weakened Democratic Party, desperate to cling to control in DC, would be a dramatic re-emergence of the "deadly" virus (driven by the numerous false positives of the PCR Test as described in detail above) ahead of the Midterms?
Killing off the PCR Test would go a long way to "solving" the "casedemic" and offer Biden and his pals a positive talking point for voters.
them are false positive. Their viral load actually is near 0. Otherwise it doesn't make sense. If you truly have covid-19, your system will remember everything from the virus, you don't need a genetically engineered molecule to instruct your system for response.
PCR test number is only used for media and public, and of course politicians.
(no message)
(no message)